Division of Digestive Surgery and Urology, Department of Digestive Surgery, Turku University Hospital, University of Turku, Turku, Finland.
Department of Surgery, University of Turku, Turku, Finland.
JAMA. 2018 Sep 25;320(12):1259-1265. doi: 10.1001/jama.2018.13201.
Short-term results support antibiotics as an alternative to surgery for treating uncomplicated acute appendicitis, but long-term outcomes are not known.
To determine the late recurrence rate of appendicitis after antibiotic therapy for the treatment of uncomplicated acute appendicitis.
DESIGN, SETTING, AND PARTICIPANTS: Five-year observational follow-up of patients in the Appendicitis Acuta (APPAC) multicenter randomized clinical trial comparing appendectomy with antibiotic therapy, in which 530 patients aged 18 to 60 years with computed tomography-confirmed uncomplicated acute appendicitis were randomized to undergo an appendectomy (n = 273) or receive antibiotic therapy (n = 257). The initial trial was conducted from November 2009 to June 2012 in Finland; last follow-up was September 6, 2017. This current analysis focused on assessing the 5-year outcomes for the group of patients treated with antibiotics alone.
Open appendectomy vs antibiotic therapy with intravenous ertapenem for 3 days followed by 7 days of oral levofloxacin and metronidazole.
In this analysis, prespecified secondary end points reported at 5-year follow-up included late (after 1 year) appendicitis recurrence after antibiotic treatment, complications, length of hospital stay, and sick leave.
Of the 530 patients (201 women; 329 men) enrolled in the trial, 273 patients (median age, 35 years [IQR, 27-46]) were randomized to undergo appendectomy, and 257 (median age, 33 years, [IQR, 26-47]) were randomized to receive antibiotic therapy. In addition to 70 patients who initially received antibiotics but underwent appendectomy within the first year (27.3% [95% CI, 22.0%-33.2%]; 70/256), 30 additional antibiotic-treated patients (16.1% [95% CI, 11.2%-22.2%]; 30/186) underwent appendectomy between 1 and 5 years. The cumulative incidence of appendicitis recurrence was 34.0% (95% CI, 28.2%-40.1%; 87/256) at 2 years, 35.2% (95% CI, 29.3%-41.4%; 90/256) at 3 years, 37.1% (95% CI, 31.2%-43.3%; 95/256) at 4 years, and 39.1% (95% CI, 33.1%-45.3%; 100/256) at 5 years. Of the 85 patients in the antibiotic group who subsequently underwent appendectomy for recurrent appendicitis, 76 had uncomplicated appendicitis, 2 had complicated appendicitis, and 7 did not have appendicitis. At 5 years, the overall complication rate (surgical site infections, incisional hernias, abdominal pain, and obstructive symptoms) was 24.4% (95% CI, 19.2%-30.3%) (n = 60/246) in the appendectomy group and 6.5% (95% CI, 3.8%-10.4%) (n = 16/246) in antibiotic group (P < .001), which calculates to 17.9 percentage points (95% CI, 11.7-24.1) higher after surgery. There was no difference between groups for length of hospital stay, but there was a significant difference in sick leave (11 days more for the appendectomy group).
Among patients who were initially treated with antibiotics for uncomplicated acute appendicitis, the likelihood of late recurrence within 5 years was 39.1%. This long-term follow-up supports the feasibility of antibiotic treatment alone as an alternative to surgery for uncomplicated acute appendicitis.
ClinicalTrials.gov Identifier: NCT01022567.
重要性:短期结果支持抗生素作为治疗单纯性急性阑尾炎的替代方法,而非手术,但长期结果尚不清楚。
目的:确定单纯性急性阑尾炎经抗生素治疗后的阑尾炎复发率。
设计、地点和参与者:这是一项对 APPAC 多中心随机临床试验的 5 年观察随访,该试验比较了阑尾切除术和抗生素治疗,其中 530 名年龄在 18 至 60 岁之间、经计算机断层扫描证实为单纯性急性阑尾炎的患者被随机分为接受阑尾切除术(n=273)或接受抗生素治疗(n=257)。初始试验于 2009 年 11 月至 2012 年 6 月在芬兰进行,最后一次随访时间为 2017 年 9 月 6 日。本分析重点评估了仅接受抗生素治疗的患者组的 5 年结局。
干预措施:开腹阑尾切除术与静脉注射厄他培南 3 天,随后口服左氧氟沙星和甲硝唑 7 天。
主要结果和测量:在这项分析中,报告的 5 年随访时的预设次要终点包括抗生素治疗后(1 年后)阑尾炎复发、并发症、住院时间和病假。
结果:在这项研究中,共有 530 名患者(201 名女性;329 名男性)参与了试验,273 名患者(中位数年龄 35 岁[IQR,27-46])被随机分配接受阑尾切除术,257 名患者(中位数年龄 33 岁,[IQR,26-47])被随机分配接受抗生素治疗。除了最初接受抗生素治疗但在 1 年内接受阑尾切除术的 70 名患者(27.3%[95%CI,22.0%-33.2%];70/256)外,另外 30 名接受抗生素治疗的患者(16.1%[95%CI,11.2%-22.2%];30/186)在 1 至 5 年内接受了阑尾切除术。2 年时的阑尾炎复发累积发生率为 34.0%(95%CI,28.2%-40.1%;87/256),3 年时为 35.2%(95%CI,29.3%-41.4%;90/256),4 年时为 37.1%(95%CI,31.2%-43.3%;95/256),5 年时为 39.1%(95%CI,33.1%-45.3%;100/256)。在抗生素组中随后因阑尾炎复发而接受阑尾切除术的 85 名患者中,76 名患有单纯性阑尾炎,2 名患有复杂性阑尾炎,7 名没有阑尾炎。5 年时,手术组的总体并发症发生率(手术部位感染、切口疝、腹痛和梗阻症状)为 24.4%(95%CI,19.2%-30.3%)(n=60/246),抗生素组为 6.5%(95%CI,3.8%-10.4%)(n=16/246)(P<0.001),手术组高 17.9 个百分点(95%CI,11.7-24.1)。两组在住院时间方面无差异,但病假时间有显著差异(手术组多 11 天)。
结论:在最初接受抗生素治疗的单纯性急性阑尾炎患者中,5 年内复发的可能性为 39.1%。这项长期随访支持单纯性急性阑尾炎单纯使用抗生素作为手术替代方法的可行性。
试验注册:ClinicalTrials.gov 标识符:NCT01022567。